A recent study by He et al. elucidated the role of DDX39B in facilitating the migration, invasion, and epithelial–mesenchymal transition (EMT) capacities of CRC cells and validated these findings in vivo [43]. The gene discussed is DDX39B; the disease is colorectal carcinoma.